LHX3 and deafness: Inactivating mutations in the human LHX3 gene typically lead to syndromic combined pituitary hormone deficiency diseases (CPHD) in pediatric patients that feature anterior pituitary hormone deficiencies and nervous system deficits, including deafness, developmental delay and a limited ability to rotate the neck [15]–[23].